The influence of chemotherapy on bone marrow in patients with chronic lymphocytic leukaemia

• Autorzy: Lemancewicz D , Dzieciol J. , Kloczko J. , Piszcz J.
• Języki publikacji: EN

Abstrakty

EN

In chronic lymphocytic leukaemia (CLL) bone marrow trephine biopsy (BMT) is not required for diagnosis but can have a significant prognostic value and can be used for the detection of the minimal residual disease (MRD) and for assessment of the effectiveness of the treatment applied. The aim of the study was to evaluate the morphological changes in bone marrow after treatment with purine nucleoside analogues cladribine and fludarabine. Bone marrow trephine biopsy was taken routinely from 15 patients with CLL. Bone marrow trephine biopsy was performed on every patient before as well as after chemotherapy. The number of cell elements of the marrow (the degree of atrophy), the patterns of bone marrow infiltration, the presence of reticulin and collagen fibres and the disturbances in bone marrow stroma were assessed. The infiltration of bone marrow by neoplastic cells was observed in all the patients before administration of chemotherapy. The infiltration was followed by an increase in the number of reticulin fibres. After the treatment a regression of the reticulin fibres was observed with the lessening of the infiltration. After the treatment the levels of marrow infiltrate were decreased. Increased hypoplasia of the bone marrow was observed after the chemotherapy.

Słowa kluczowe

EN

human disease; lymphoid infiltration; bone marrow; reticulin fibrosis; biopsy; chronic lymphocytic leukemia

• Wydawca: -
• Czasopismo: Folia Morphologica
• Rocznik: 2004
• Tom: 63
• Numer: 4
• Opis fizyczny: p.485-489,fig.,ref.

Twórcy

autor

Lemancewicz D

• Medical University, Mickiewicza 2A, 15-230 Bialystok, Poland

autor

Dzieciol J.

autor

Kloczko J.

autor

Piszcz J.

Bibliografia

• 1. Bain BJ, Clark DM, Lampert IA, Wilkins BS (2001) Lymphoproliferative disorders. In: Bone marrow pathology. Third Edition, Blackwell Science: pp. 231–331.
• 2. Bauermeister DE (1971) Quantitation of bone marrow reticulin: A normal range. Am J Clin Pathol, 56: 24–31.
• 3. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O’Brien S, Rai KR (1996) National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood, 87: 4990–4997.
• 4. Cheson BD (1995) Infections and immunosuppressive complications of purine analog therapy. J Clin Oncol, 13: 2431–2448.
• 5. Colović MD, Wiernik PH, Janković GM, Vidović AD, Janośević S, Basara NM (1999) Circulating haematopoietic progenitor cells in primary and secondary myelofibrosis: relation to collagen and reticulin fibrosis. Eur J Haemtol, 62: 155–159.
• 6. Gala JL. Guiot Y, Delannoy A, Scheiff JM, Philippe M, Martiat P (1999) Use of image analysis and immunostaining of bone marrow trephine biopsy specimens to quantify residual disease in patients with B-cell chronic lymphocytic leukemia. Mod Pathol, 12: 391–399.
• 7. Keating MJ (1990) Fludarabine phosphate in the treatment of chronic lymphocytic leukemia. Semin Oncol, 17: 49–62.
• 8. Kundel DW, BreKundel DW, Brecher G, Bodsy GP, Brittin GM (1964) Reticulin fibrosis and bone infarction in acute leukemia. Implications for prognosis. Blood, 23: 526–544.
• 9. Mioduszewska O (1998) Patologia chłoniaków i ziarnicy złośliwej. In: Stachura J (Editor-in-Chief). Polish Journal of Pathology, 49 (Suppl 4): pp. 28–30.
• 10. Montserrat E, Rozman C (1995) Chronic lymphocytic leukemia: present status. Ann Oncol, 6: 219–235.
• 11. Oudat R, Keating MJ, Lerner S, O’Brien S, Albitar M (2002) Significance of the levels of bone marrow lymphoid infiltrate in chronic lymphocytic leukemia patients with nodular partial remission. Leukemia, 16: 632–635.
• 12. Robak T (2002) The role of nucleoside analogues in the treatment of chronic lymphocytic leukaemia — lessons learned from prospective ranomized trials. Leuk Lymphoma, 43: 537–548.
• 13. Rozman C, Hernandez- Nieto L, Montserrat E, Brugues R (1981) Prognostic significance of bone marrow patterns in chronic lymphocytic leukaemia. Br J Haematol, 47: 529–537.
• 14. Sah SP, Matutes E, Wotherspoon AC, Morilla R, Catovsky D (2003) A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders. J Clin Pathol, 56: 129–132.
• 15. Smith A, Bruton J (1977) Color atlas of histological staining techniques. Year Book Medical Publishers, INC, Chicago.